Eye News and Research

Latest Eye News and Research

Normobaric oxygen treatment shows promise for neurorehabilitation

Normobaric oxygen, delivered at the same pressure as the atmosphere, is often used to maximize brain cell survival in patients with neurological trauma.

10 Jul 2023

Research uncovers mechanism linking deep sleep to blood sugar control

Researchers have known that a lack of quality sleep can increase a person's risk of diabetes. What has remained a mystery, however, is why.

7 Jul 2023

Study traces the natural evolution of earliest stages of human cancers

Cancer cells-to-be accumulate a series of specific genetic changes in a predictable and sequential way years before they are identifiable as pre-malignancies, researchers at Stanford Medicine have found.

7 Jul 2023

AI tool can rapidly decode brain tumor DNA during surgery

Scientists have designed an AI tool that can rapidly decode a brain tumor's DNA to determine its molecular identity during surgery - critical information that under the current approach can take a few days and up to a few weeks.

7 Jul 2023

OCT imaging method can improve diagnosis of multiple sclerosis

A study conducted by researchers from the Department of Neurology at MedUni Vienna and University Hospital Vienna has demonstrated for the first time that diagnosis of multiple sclerosis (MS) can be significantly improved by additionally measuring the thickness of retinal layers in the eye.

6 Jul 2023

New therapy to mitigate fragile X syndrome may be on the horizon

An antisense therapy developed by Joel D. Richter, PhD, Sneha Shah, PhD, and Jonathan K. Watts, PhD, at UMass Chan Medical School and Elizabeth Berry-Kravis, MD, PhD, at RUSH University Medical Center, restores production of the protein FMRP in cell samples taken from patients with fragile X syndrome.

5 Jul 2023

Mount Sinai launches first-of-its-kind center for ophthalmic AI

The Icahn School of Medicine at Mount Sinai has launched the Center for Ophthalmic Artificial Intelligence and Human Health, the first of its kind in New York and one of the first in the United States.

5 Jul 2023

New biomarker for major depressive disorder identified

In appearance, the human brain's outermost layer, called the cortex, is a maze of tissue folds. The peaks or raised surfaces of these folds, called gyri, play an important role in the proper functioning of the brain.

4 Jul 2023

How does space affect the immune system of astronauts?

Research explores the effects of microgravity and radiation on the immune system in space conditions. It emphasizes the need to understand these effects for future long-duration space missions and highlights knowledge gaps for further investigation.

2 Jul 2023

Non-invasive technique can help identify infants at high risk for retinopathy of prematurity

Research from Ann & Robert H. Lurie Children's Hospital of Chicago promises to spare many premature infants from undergoing invasive eye exams to detect retinopathy of prematurity (ROP), the most common cause of preventable lifelong blindness in children in the U.S.

29 Jun 2023

Cambridge psychologists develop new test to measure a person’s susceptibility to misinformation

University of Cambridge psychologists have developed the first validated "misinformation susceptibility test": a quick two-minute quiz that gives a solid indication of how vulnerable a person is to being duped by the kind of fabricated news that floods online spaces.

28 Jun 2023

Novel computational tool helps analyze complex genetic regions

GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic and clinical insights, today published a paper in Nature Methods, titled "Multiscale analysis of pangenomes enables improved representation of genomic diversity for repetitive and clinically relevant genes," in which researchers developed a new computational tool, the PanGenome Research-Tool Kit (PGR-TK), for scalable analysis of clinically relevant genes that were previously too complex to analyze.

27 Jun 2023

World-renowned researcher receives top award for contributions to clinical psychopharmacology

Dennis Charney, MD, the Anne and Joel Ehrenkranz Dean of the Icahn School of Medicine at Mount Sinai and President for Academic Affairs of the Mount Sinai Health System, has received the prestigious Donald Klein Lifetime Achievement Award from the American Society for Clinical Psychopharmacology (ASCP).

26 Jun 2023

Europe's battle against Aedes mosquitoes: growing threat of mosquito-borne diseases

Study described how cases of all types of mosquito-borne diseases are increasing in Europe.

26 Jun 2023

Bath Babylab to explore how young children see and interact with the world

A new facility at the University of Bath will officially open its doors this weekend (Saturday 24 June) at a public event to showcase the work of the Bath Babylab.

24 Jun 2023

New platform technology bridges the gap between microscopic analysis and multiplex imaging

Researchers at the Ludwig Center at Harvard have developed a platform technology for imaging that enables integration of the methods of microscopic analysis long employed in pathology laboratories with the visualization of multiple molecular markers in individual cells that is now rapidly advancing in research labs.

22 Jun 2023

Study reveals why some women with deadly ovarian cancer respond better to treatment than others

New research is increasing our understanding about why some women with the most lethal form of ovarian cancer respond much better to treatment than others.

21 Jun 2023

Gestational diabetes influences diabetes risk and blood sugar control

People who develop diabetes following pregnancy were significantly less likely to be able to bring it under control if they had experienced gestational diabetes during their pregnancy, especially if they were Black or Hispanic, according to a Mount Sinai study published on June 21 in the journal Diabetes Care.

21 Jun 2023

New treatment could be instrumental in restoring the blood-brain barrier's normal function

There's a bouncer in everyone: The blood-brain barrier, a layer of cells between blood vessels and the rest of the brain, kicks out toxins, pathogens and other undesirables that can sabotage the brain's precious gray matter.

20 Jun 2023

Phase I clinical study of TCR NK cell therapy for sarcoma expected to commence later this year

The University of Texas MD Anderson Cancer Center and Replay today announced that the Food & Drug Administration (FDA) has issued a 'safe to proceed' for the Investigational New Drug (IND) application for NY-ESO-1 TCR/IL-15 NK, an engineered T cell receptor natural killer (TCR NK) cell therapy for advanced synovial sarcoma and myxoid/round cell liposarcoma.

20 Jun 2023

Eye News and Research

Latest Eye News and Research

Normobaric oxygen treatment shows promise for neurorehabilitation

Research uncovers mechanism linking deep sleep to blood sugar control

Study traces the natural evolution of earliest stages of human cancers

AI tool can rapidly decode brain tumor DNA during surgery

OCT imaging method can improve diagnosis of multiple sclerosis

New therapy to mitigate fragile X syndrome may be on the horizon

Mount Sinai launches first-of-its-kind center for ophthalmic AI

New biomarker for major depressive disorder identified

How does space affect the immune system of astronauts?

Non-invasive technique can help identify infants at high risk for retinopathy of prematurity

Cambridge psychologists develop new test to measure a person’s susceptibility to misinformation

Novel computational tool helps analyze complex genetic regions

World-renowned researcher receives top award for contributions to clinical psychopharmacology

Europe's battle against Aedes mosquitoes: growing threat of mosquito-borne diseases

Bath Babylab to explore how young children see and interact with the world

New platform technology bridges the gap between microscopic analysis and multiplex imaging

Study reveals why some women with deadly ovarian cancer respond better to treatment than others

Gestational diabetes influences diabetes risk and blood sugar control

New treatment could be instrumental in restoring the blood-brain barrier's normal function

Phase I clinical study of TCR NK cell therapy for sarcoma expected to commence later this year

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Eye News and Research

Latest Eye News and Research

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in